U. Martinowitz - Publications, H-index & Citations

U. Martinowitz

chaim sheba medical center

51H指数

260论文数

8.8K被引数

收录论文 38

发表时间

Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial

THROMBOSIS AND HAEMOSTASIS

IF4.3

2017-11-22

PREAI

Kenet, Gili; Stenmo, Camilla B.; Blemings, Allan; Wegert, Wolfgang; Goudemand, Jenny; Krause, Manuela; Schramm, Wolfgang; Kirchmaier, Carl; Martinowitz, Uri

The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency

THROMBOSIS RESEARCH

IF3.4

2015-08-01

PREAI

Livnat, Tami; Shenkmana, Boris; Martinowitz, Uri; Zivelin, Ariella; Dardik, Rima; Tamarin, Ilia; Mansharov, Rachel; Budnik, Ivan; Salomon, Ophira

Results of a phase I/II open-label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

HAEMOPHILIA

IF3

2015-05-20

OAAI

Martinowitz, U.; Lissitchkov, T.; Lubetsky, A.; Jotov, G.; Barazani-Brutman, T.; Voigt, C.; Jacobs, I.; Wuerfel, T.; Santagostino, E.

Survival of hepatitis C-infected haemophilia patients is predicted by presence of cirrhosis but not by anti-viral treatment

ANNALS OF HEPATOLOGY

IF4.4

2014-11-01

OAAI

Maor, Yaakov; Schapiro, Jonathan M.; Bashari, Dalia; Martinowitz, Uri

Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

HAEMOPHILIA

IF3

2013-11-20

OAAI

Lalezari, S.; Martinowitz, U.; Windyga, J.; Enriquez, M. M.; Delesen, H.; Schwartz, L.; Scharrer, I.

Surfactant impairs coagulation in-vitro: A risk factor for pulmonary hemorrhage?

THROMBOSIS RESEARCH

IF3.4

2013-11-01

PREAI

Strauss, Tzipora; Rozenzweig, Naomi; Rosenberg, Nurit; Shenkman, Boris; Livnat, Tami; Morag, Iris; Fruchtman, Yariv; Martinowitz, Uri; Kenet, Gili

Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study

HAEMOPHILIA

IF3

2013-05-10

PREAI

Livnat, T.; Martinowitz, U.; Azar-Avivi, S.; Zivelin, A.; Brutman-Barazani, T.; Lubetsky, A.; Kenet, G.

Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel

HAEMOPHILIA

IF3

2012-08-23

PREAI

Maor, Y.; Morali, G.; Bashari, D.; Penaranda, G.; Schapiro, J. M.; Martinowitz, U.; Halfon, P.

Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A

HAEMOPHILIA

IF3

2011-03-28

PREAI

Martinowitz, U.; Bjerre, J.; Brand, B.; Klamroth, R.; Misgav, M.; Morfini, M.; Santagostino, E.; Tiede, A.; Viuff, D.

Recombinant factor concentrates may increase inhibitor development: a single centre cohort study

HAEMOPHILIA

IF3

2011-02-07

PREAI

Strauss, T.; Lubetsky, A.; Ravid, B.; Bashari, D.; Luboshitz, J.; Lalezari, S.; Misgav, M.; Martinowitz, U.; Kenet, G.

Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C Fibrotest或Fibroscan用于评估感染丙型肝炎的血友病患者的肝纤维化

HAEMOPHILIA

IF3

2009-12-29

PREAI

Maor, Y.; Halfon, P.; Bashari, D.; Penaranda, G.; Morali, G.; Klar, R.; Bar-Meir, S.; Martinowitz, U.; Oren, R.

Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors

HAEMOPHILIA

IF3

2009-08-26

PREAI

Kenet, G.; Lubetsky, A.; Luboshitz, J.; Ravid, B.; Tamarin, I.; Varon, D.; Martinowitz, U.

A Rapidly Progressive, Life-Threatening Postpartum Hemorrhage Successful Treatment With Anti-CD-20 Monoclonal Antibody

OBSTETRICS AND GYNECOLOGY

IF4.7

2009-08-01

PREAI

Mei-Dan, Elad; Walfisch, Asnat; Martinowitz, Uri; Hallak, Mordechai

Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors

HAEMOPHILIA

IF3

2009-06-24

PREAI

Martinowitz, U.; Livnat, T.; Zivelin, A.; Kenet, G.

Physical activity participation and bleeding characteristics in young patients with severe haemophilia 年轻重症血友病患者的体力活动参与和出血特征

HAEMOPHILIA

IF3

2009-04-21

PREAI

Tiktinsky, R.; Kenet, G.; Dvir, Z.; Falk, B.; Heim, M.; Martinowitz, U.; Katz-Leurer, M.

Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma

HAEMOPHILIA

IF3

2008-07-08

PREAI

Livnat, T.; Martinowitz, U.; Zivelin, A.; Seligsohn, U.

Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors

SEMINARS IN HEMATOLOGY

IF4.1

2008-04-01

PREAI

Kenet, Gili; Martinowitz, Uri

Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experience

HAEMOPHILIA

IF3

2008-01-18

PREAI

Maor, Y.; Schapiro, J. M.; Bashari, D.; Lurie, Y.; Safadi, R.; Segol, O.; Paritsky, M.; Rachlis, Z.; Avidan, B.; Bar-Meir, S.; Martinowitz, U.

Phacoemulsification of cataract in patients receiving coumadin theraphy: Ocular and hematologic risk assessment

AMERICAN JOURNAL OF OPHTHALMOLOGY

IF4.2

2007-11-01

PREAI

Barequet, Irina S.; Sachs, Dan; Priel, Ayelet; Wasserzug, Yael; Martinowitz, Uri; Moisseiev, Joseph; Salomon, Ophira

Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients

HAEMOPHILIA

IF3

2007-08-03

PREAI

Maor, Y.; Cales, P.; Bashari, D.; Kenet, G.; Lubetsky, A.; Luboshitz, J.; Schapiro, J. M.; Penaranda, G.; Bar-Meir, S.; Martinowitz, U.; Halfon, P.

研究方向